Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
deals
2
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
adeno-associated virus
alexandria venture investments
alexion pharmaceuticals
alnylam pharmaceutials
altitude life science ventures
american society of gene and cell therapy
arch venture partners
arrowhead pharmaceuticals
boehringer ingelheim
boston
boxer capital
clinical trials
dicerna pharmaceuticals
dravet syndrome
ed kaye
eli lilly
encoded therapeutics
gene therapy
generation bio
hemophilia
hepatitis b
illumina
illumina ventures
indiana blog main
indiana top stories
johnson & johnson
matrix capital management
menlo ventures
neurodegenerative diseases
new york blog main
new york top stories
What
long
2
×
abandoning
ago
baggage
companies
crude
cuts
cutting
deal
despite
development
dicerna
edge
effects
encoded
free
gene
gets
help
illumina’s
interference
lasting
limited
limits
medicine
medicines
nabs
pharma
progress
promising
push
remains
rna
rnai
signs
single
small
therapy
therapy’s
treatment
Language
Current search:
biotech
×
long
×
deals
×
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M